- Exclusive: Obesity biotech Verdiva hires ex-Metsera CMO as crucial readouts nearLong-acting obesity pill developer Verdiva Bio has a new chief medical officer, and he comes from a biotech that was looking at very similar technology — and got bought for $10 billion not long ago…Endpoints · 1d ago↗ source
- Teladoc is moving beyond its single-visit roots with new launchOver two decades ago, Teladoc built its business around quick doctor visits that didn't happen in person. Now, it's saying that the model of one-off virtual appointments is no longer enough. The…Endpoints · 1d ago↗ source
- Filing of bipartisan Senate bill boosts momentum for office of men’s healthMirroring the bipartisan bill introduced in the House, the measure would require a study from the GAO on the state of men’s health in the U.S. to be presented within…